GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » EV-to-FCF

Heart Test Laboratories (Heart Test Laboratories) EV-to-FCF : 0.30 (As of May. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Heart Test Laboratories's Enterprise Value is $-1.95 Mil. Heart Test Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 was $-6.42 Mil. Therefore, Heart Test Laboratories's EV-to-FCF for today is 0.30.

The historical rank and industry rank for Heart Test Laboratories's EV-to-FCF or its related term are showing as below:

HSCS' s EV-to-FCF Range Over the Past 10 Years
Min: -6.06   Med: -1.35   Max: 0.42
Current: 0.3

During the past 4 years, the highest EV-to-FCF of Heart Test Laboratories was 0.42. The lowest was -6.06. And the median was -1.35.

HSCS's EV-to-FCF is ranked better than
94.46% of 361 companies
in the Medical Devices & Instruments industry
Industry Median: 28.78 vs HSCS: 0.30

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Heart Test Laboratories's stock price is $6.20. Heart Test Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.000. Therefore, Heart Test Laboratories's PE Ratio for today is At Loss.


Heart Test Laboratories EV-to-FCF Historical Data

The historical data trend for Heart Test Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories EV-to-FCF Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
EV-to-FCF
- - - -1.53

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.44 -1.53 -1.92 -0.89 -0.55

Competitive Comparison of Heart Test Laboratories's EV-to-FCF

For the Medical Devices subindustry, Heart Test Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heart Test Laboratories's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Heart Test Laboratories's EV-to-FCF falls into.



Heart Test Laboratories EV-to-FCF Calculation

Heart Test Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-1.952/-6.419
=0.30

Heart Test Laboratories's current Enterprise Value is $-1.95 Mil.
Heart Test Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heart Test Laboratories  (NAS:HSCS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Heart Test Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.20/-48.000
=At Loss

Heart Test Laboratories's share price for today is $6.20.
Heart Test Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-48.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Heart Test Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092

Heart Test Laboratories (Heart Test Laboratories) Headlines

From GuruFocus

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

By sperokesalga sperokesalga 04-17-2023